Dimensional Fund Advisors’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,346,341
| Closed | -$29.2M | – | 3376 |
|
|
2017
Q2 | $29.2M | Sell |
1,346,341
-94,693
| -7% | -$1.72M | 0.01% | 1767 |
|
|
2017
Q1 | $20.2M | Sell |
1,441,034
-80,651
| -5% | -$1.32M | 0.01% | 1989 |
|
|
2016
Q4 | $28.5M | Sell |
1,521,685
-110,854
| -7% | -$1.88M | 0.01% | 1686 |
|
|
2016
Q3 | $27M | Sell |
1,632,539
-40,314
| -2% | -$597K | 0.01% | 1672 |
|
|
2016
Q2 | $22.5M | Sell |
1,672,853
-63,646
| -4% | -$928K | 0.01% | 1738 |
|
|
2016
Q1 | $26.6M | Sell |
1,736,499
-70,135
| -4% | -$1.1M | 0.02% | 1576 |
|
|
2015
Q4 | $35.9M | Sell |
1,806,634
-233,909
| -11% | -$4.45M | 0.02% | 1207 |
|
|
2015
Q3 | $35.5M | Sell |
2,040,543
-40,342
| -2% | -$821K | 0.02% | 1167 |
|
|
2015
Q2 | $42.1M | Sell |
2,080,885
-227,758
| -10% | -$4.4M | 0.03% | 1043 |
|
|
2015
Q1 | $40.6M | Sell |
2,308,643
-392,174
| -15% | -$6.68M | 0.03% | 1050 |
|
|
2014
Q4 | $44M | Sell |
2,700,817
-26,870
| -1% | -$493K | 0.03% | 885 |
|
|
2014
Q3 | $60.2M | Buy |
2,727,687
+11,442
| +0.4% | +$234K | 0.04% | 541 |
|
|
2014
Q2 | $54.6M | Buy |
2,716,245
+86,977
| +3% | +$1.47M | 0.04% | 632 |
|
|
2014
Q1 | $48.9M | Buy |
2,629,268
+4,037
| +0.2% | +$55.6K | 0.04% | 664 |
|
|
2013
Q4 | $26.5M | Sell |
2,625,231
-21,393
| -0.8% | -$259K | 0.02% | 1218 |
|
|
2013
Q3 | $34.1M | Sell |
2,646,624
-6,571
| -0.2% | -$80.8K | 0.03% | 828 |
|
|
2013
Q2 | $31.5M | Buy |
+2,653,195
| New | +$28.7M | 0.03% | 823 |
|
Other funds holding AMRI
Dimensional Fund Advisors's AMRI Position: Q3 2017 in Review
Dimensional Fund Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 1,346,341 shares — an estimated $29.2M sold.
Dimensional Fund Advisors first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $60.2M in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.
- Dimensional Fund Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,346,341 Albany Molecular Research Inc shares in Q3 2017, an estimated $29.2M.
- Dimensional Fund Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
- Dimensional Fund Advisors's Albany Molecular Research Inc position peaked at $60.2M in Q3 2014.
- 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.
Based on Dimensional Fund Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.